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hexosamine pathway via conversion of fructose 6-phosphate to glucosamine 6-phosphate by the rate-limiting enzyme glutamine: fructose-6-phosphate amidotransferase (GFAT) (35) . The hexosamine pathway sensitizes cells to the effects of high extracellular glucose concentrations and may be important for cellular glucose sensing (20, 35) . The end-product of the hexosamine pathway, uridine diphosphate N-acetylglucosamine (UDP-GlcNAc), is a substrate for O-glycosylation (O-GlcNAcylation) of intracellular proteins, including transcription factors and signaling molecules (21, 53) , and the hexosamine pathway influences the expression of genes related to vascular injury, insulin resistance, and vascular inflammation (5, 10, 20, 21) .
Prior studies have employed a relatively wide range of extracellular glucosamine concentrations (1-10 mM) to examine whether exposure to this metabolite, which is known to reflect increased hexosamine flux, recapitulates some of the effect of high glucose on the fate of various cell types, including cardiomyocytes, pancreatic ␤-cells, and MCs (13, 21, 31, 33, 57) . As a result, the reported effects of glucosamine on cell behavior have varied widely, likely reflecting the large variability in the concentrations to which cells are exposed in specific studies. In some of these studies, glucosamine exposure caused apoptosis (13, 31) , whereas others have suggested growth arrest and hypertrophy (37, 57) . Yet, other studies suggest a protective role for glucosamine following exposure to noxious extracellular stimuli (3, 4) . This variability may be due, at least in part, to differences between specific cell populations, but it is also possible that there is an effect of glucosamine concentration on cell fate.
Given the diverse effects of hexosamine pathway flux on cellular behavior, our earlier observations that the hexosamine flux may mediate some of the detrimental effects of high glucose (20, 21) , and the important observation that GFAT immunostaining is increased in the human diabetic kidney (45), we hypothesized that variable flux through the hexosamine pathway may also be an important determinant of both proliferation and apoptosis in MC exposed to high glucose concentrations. Accordingly, we examined the effects of glucosamine on MC proliferation and apoptosis, and we related these effects to the response to high glucose concentrations.
EXPERIMENTAL PROCEDURES
Materials. D-glucose, L-glucose, O-diazoacetyl-L-serine (azaserine), 6-diazo-5-oxonorleucine (DON), D-glucosamine, paraformaldehyde, and anti-actin antibody were obtained from Sigma-Aldrich (St.
Louis, MO). O-(2-acetamido-2-deoxy-D-glucopyranosylidene) amino-
N-phenylcarbamate (PUGNAC) was supplied by TRC (Toronto, ON, Canada). DMEM with and without phenol red (product no 11504-020, 5.6 mM glucose; product no. 21063-029, 25 mM glucose) and FBS were purchased from GIBCO/Invitrogen (Grand Island, NY), whereas trypsin (0.05%)/EDTA (0.53 mM) and penicillin (10,000 U/ml)/ streptomycin (10,000 g/ml) were from Mediatech (Herndon, VA). Effectene transfection reagent was procured from Qiagen (Valencia, CA). Polyclonal anti-proliferating cell nuclear antigen (PCNA; sc-7907) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA) while polyclonal anti-caspase-3 was obtained from Biovision Research (Mountain View, CA), and RL-2 (antibody against OGlcNAc modified proteins, catalog no. MA1-072) was from Affinity BioReagents (Golden, CO). In addition, antibodies to mammalian target of rapamycin (mTOR), phosphorylated mammalian target of rapamycin [phospho-mTOR (Ser 2448 )], and total regulatory-associated protein of mTOR (Raptor) were purchased from Cell Signaling Technology (Boston, MA). Rapamycin was procured from LKT Laboratories (St. Paul, MN). All tissue culture plates were from BD Labware (Franklin Lakes, NJ).
Cell culture. Animal protocols were undertaken after approval from, and in accordance with, guidelines of the Animal Care Committee (UACC) at the University of Toronto. Sprague-Dawley rat MC, prepared as previously described (22) , were cultured in DMEM supplemented with 10% FBS, streptomycin (100 g/ml), penicillin (100 U/ml), and 2 mM glutamine at 37°C in 95% air-5% CO 2 (20) . Cells from passage 8 -15 were used throughout these studies. For time-course studies, 16 h after seeding the cells, the media were changed to DMEM-0.5% FBS, and MC were exposed to physiological glucose (5.6 mM), high glucose (25 mM), or glucosamine (0.05-10 mM) for 24 -96 h. Analyses were performed as outlined below.
Plasmids. The plasmid pCIS (empty vector) and pCIS-GFAT (containing the human GFAT gene) were generously supplied by Dr. M. J. Quon and have been described previously (5) .
Transient transfection of MC. MC were plated on six-well plastic plates (1.5 ϫ 10 5 cells/well) or on glass cover slips in 12-well plastic plates (7.5 ϫ 10 4 cells/well), and transfection was carried out 24 h later using Effectene as we have previously described (20) . MC (70 -80% confluent) was transfected with 0.4 g pCIS or pCIS-GFAT and cultured for 18 h in DMEM containing FBS (20%) and 5.6 mM glucose. Transfection efficiency was estimated at 30 -40% using green fluorescent protein (20) . Subsequently, the media were changed to DMEM-0.5% FBS and glucose (5.6 or 25 mmol/l), with and without the GFAT inhibitor azaserine (10 mM).
Flow cytometry. MCs were seeded (1 ϫ 10 6 /100-mm plate) in DMEM-10% FBS with penicillin and streptomycin. Sixteen hours subsequent to this, plates were washed (two times with PBS) and cultured in DMEM-0.5% FBS medium containing either physiological glucose (5.6 mM), high glucose (25 mM), or glucosamine (0.05-10 mM) for up to 48 h. Cells were harvested by trypsinization, washed (two times with PBS/1,000 rpm for 5 min per wash), and resuspended in PBS. (5 ϫ 10 6 /0.5 ml). Cells were fixed with 70% ethanol (4°C for 60 min).
Following centrifugation (1,500 rpm/10 min), cells were resuspended in propidium iodide cocktail [10 mM Tris · Cl (pH 7.0), 5 ϫ 10 Ϫ6 M MgCl2, 50 g/ml propidium iodide, and 25 ϫ 10 Ϫ6 g/ml RNaseA] and incubated at 37°C for 30 min. Cells were filtered (100-m filter) and then incubated (4°C) for an additional 18 h. Flow cytometry was performed with BD FACScan (Becton-Dickinson, San Jose, CA) to acquire the data utilizing the red fluorescence of propidium iodide (excitation 488 nm; emission 670 nm).
TdT-dUTP nick end-labeling assay. MC apoptosis, following transfection or exposure to high glucose or glucosamine, was determined using a commercially available in situ cell death detection kit and performed in accordance with the manufacturer's specification (product no.: G3250; Promega, Madison, WI). MC (passage 8 -15) were seeded on plastic plates (100 mm, 3.5 ϫ 10 6 cells/plate) and maintained in DMEM-10% FBS for 24 h. Culture media were changed to DMEM-0.5% FBS and glucosamine (0.25-10 mM), with and without azaserine (10 M) or DON (10 M), and MC were cultured for an additional 24 h. Media were removed, and the cells were washed three times with ice-cold PBS, dislodged by treatment with trypsin (0.05%)/ EDTA (0.53 mM), followed by centrifugation (300 g at 4°C for 5 min) and dispersion in PBS (0.5 ml). Cells were fixed in 4% paraformaldehyde (4°C/45 min), washed with PBS (two times), and then treated with ethanol (70% at 4°C). Following additional PBS washes, TdTdUTP nick end-labeling (TUNEL) assay was performed as we have previously described (54) . Subsequent to TUNEL, cells were stained with propidium iodide (5 g/ml in PBS containing 250 g/ml RNase at room temperature for 30 min). Stained cells were analyzed by flow cytometry, using a FACScan (see above) to acquire the data. Subsequently, green fluorescence of fluorescein-12-dUTP (excitation 488 nm; emission 535 nm) and red fluorescence of propidium iodide (excitation 488 nm; emission 670 nm) were measured.
Proliferation assay. MC proliferation was assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) protocol, in accordance with the manufacturer's specifications (Product no: v-13154; Invitrogen/Molecular Probes). The tetrazolium-based dye is actively taken up by living cells and converted to a membrane impermeable, nondiffusible product that is quantified at 570 nm (41) . Cells (passages 8 -15) were seeded in 96-well plates (7,000 cells/well) in DMEM-10% FBS-antibiotics (penicillin/streptomycin) for 16 h. Subsequently, cells were cultured in DMEM without phenol red-0.5% FBS with or without high glucose (25 mM) or varying glucosamine concentration for up to 96 h. The MTT assay was subsequently performed; it measures the formation of a membrane-impermeable product that is quantified at 570 nm. All conditions were performed in replicates of seven.
Protein isolation and Western blotting analyses. Cultures were serum-starved overnight before exposure to high glucose or glucosamine. After incubation with glucosamine, media were removed, and the cells were washed one time with ice-cold PBS. PBS was removed, and cells were harvested under nondenaturing conditions. Cells were incubated with lysis buffer (M-PER Mammalian Protein Extraction; Pierce, Rockford, IL)/protease inhibitor cocktail (SigmaAldrich) for 10 min at room temperature Cells were then scraped in microcentrifuge tubes on ice and centrifuged (14,000 g at 4°C for 10 min). The supernatant was transferred to a fresh microcentrifuge tube, and the protein concentration was measured with Bio-Rad protein assay reagent (Bio-Rad, Hercules, CA).
Protein (20 -30 g ) was separated on Tris · HCl SDS-PAGE (4 -20%). After electroblotting to a polyvinyledene fluoride membrane (Immobilon-P Transfer Membrane; Millipore, Billerica, MA), membranes were incubated (overnight at 4°C) with 10 ml of blocking buffer [1 ϫ PBS and 0.05% Tween 20 (TPBS), 0.1% BSA with 2% wt/vol nonfat dry milk], and then 1 h at room temperature with primary antibody (0.2-0.5 g/ml) in 5 ml of antibody dilution buffer (TPBS with 0.1% BSA). Membranes were then washed six times with TPBS and then incubated with horseradish peroxidase-conjugated anti-rabbit secondary antibody (0.03-0.07 g/ml) in 5 ml of antibody dilution buffer for 1 h at room temperature. After six further TPBS washes, the membrane was incubated with ECL Plus Western Blotting Detection Reagent (GE Healthcare, Buckinghamshire, UK) for 5 min and then exposed to X-ray film (CL-XPosure; Pierce).
Immunoprecipitation of PCNA. Protein (100 g) from lysed cells was used for PCNA immunoprecipitation using a commercially available kit (Catch and Release version 2.0 Reversible Immunoprecipitation System, catalog no. 17-500) according to the manufacturer's specification (Upstate Cell Signalling Solutions). In brief, cell lysate (100 g) with anti-PCNA antibody (1 g), antibody capture affinity ligand (that binds the antibody-antigen complex and tethers it to a resin), were mixed in microcentrifuge spin columns (18 h at 4°C). Subsequently, unbound proteins were removed by centrifugation, and captured antibody-antigen complex was eluted and used for Western blotting analyses. In this case, RL-2 (0.1 g/ml) serves as the primary antibody to determine whether PCNA undergoes posttranslational O-GlcNAcylation (21) .
Statistical analysis. Statistical analyses were performed with the INSTAT statistical package (GraphPad Software, San Diego, CA).
The difference between means was analyzed using the Bonferroni multiple-comparison test. Significance was defined as P Ͻ 0.05.
RESULTS

Glucosamine causes MC proliferation in a time-dependent manner.
High glucose concentrations induce proliferation in several cell types, including glomerular MC (9, 66) . To determine if the hexosamine pathway metabolite, glucosamine, also influences MC proliferation in a similar manner, MC were grown in 0.5% FBS (37°C for 18 h) and exposed to either glucose or glucosamine for 24 h.
Both high glucose (25 mM) and glucosamine (0.25 and 1 mM) led to an early and significant increase in MC proliferation compared with physiological glucose concentrations (5.6 mM) (Fig. 1A) , whereas 10 mM glucosamine did not stimulate MC proliferation. L-Glucose (25 mM) did not significantly influence MC proliferation (data not shown). Given the observation that low glucosamine concentration enhanced proliferation, to further explore the effects on MC proliferation, MC were maintained in medium with 5.6 mM glucose or in media supplemented with either high glucose (25 mM) or low concentrations of glucosamine (0.05-0.2 mM) for 24 -96 h ( Increased hexosamine flux mediates high glucose-induced proliferation. To determine if flux through the hexosamine pathway mediates the effect of 25 mM glucose on MC proliferation, we initially determined the effect of these conditions on O-GlcNAcylation, the end-reaction of the hexosamine pathway (17) . O-GlcNAcylated species were identified by immunoblotting with an antibody (RL-2) that detects proteins that are affected by this posttranslational modification. As depicted in Fig. 3A , both high glucose and glucosamine (0.05 mM), increased O-GlcNAcylated species as reported by other investigators (60) . Subsequently, cells were treated with either an inhibitor of GFAT, DON, or an inhibitor of O-linked N-
GFAT is the rate-limiting enzyme for entry of glucose in the hexosamine pathway, whereas O-GlcNAcase catalyzes the removal of N-acetylglucosamine (GlcNAc) from O-GlcNAcylated proteins (18) . The GFAT inhibitor, DON, significantly attenuated high glucose-induced MC proliferation (P Ͻ 0.05, n ϭ 5) and, as expected, did not affect glucosamine-induced MC proliferation (Fig. 3B) . In contrast, inhibition of O-GlcNAcase with PUGNAC (20 nM) increased proliferation of cells maintained at a physiological concentration (5.6 mM) of glucose (P Ͻ 0.05, n ϭ 4). In addition, when cells were cultured in media with PUGNAC, there were increases in O-GlcNAcylated species (Supplemental Fig. S2 ), suggesting that O-GlcNAcylation may play a role in MC proliferation. It is worth noting that neither DON (48 h exposure) nor PUGNAC (24 h of exposure) had any significant influence on the proliferation of cells grown in media containing physiological glucose (Supplemental Fig. S3) .
High glucose and glucosamine influences PCNA protein levels. PCNA (also known as cyclin) is a cofactor of DNA polymerase that plays a central role in DNA replication. Intracellular levels of PCNA are highly correlated with cell proliferation (40) . PCNA is increased in MCs exposed to high glucose for 24 h (66). Given the observed effect of glucosamine on cell proliferation, we sought to determine if PCNA expression was also increased by glucosamine (0.05 mM). Compared with MC grown in 5.6 mM glucose, MC cultured in high glucose (25 mM) exhibited a 1.5-to 2-fold increase in PCNA protein levels by 12 h that were maintained for up to 48 h (P Ͻ 0.05, n ϭ 4). The effect of 0.05 mM glucosamine on PCNA expression was delayed compared with 25 mM glucose. PCNA levels were increased 12 h after exposure to glucosamine, and the levels remained elevated after 48 h (Fig. 4, A-C) . PCNA is known to undergo extensive posttranslational modification, including acetylation, sumoylation, and phosphorylation that may affect the activity of the protein (28, 43) . O-GlcNAcylation is a dynamic posttranslational modification that can also influence protein activity (58) , but it is unclear if PCNA is O-GlcNAcylated. As noted earlier, high glucose (25 mM) and glucosamine (0.05 mM) increased O-GlcNAcylation of proteins in MC lysates compared with 5.6 mM glucose (Fig. 3A) . Consequently, PCNA immunoprecipitation followed by immunoblotting with RL-2 was employed to determine whether PCNA may be modified by O-GlcNAcylation and, if this is the case, how this modification may be affected by high glucose (25 mM) and glucosamine (0.05 mM). Indeed, we observed that PCNA was O-GlcNAcylated in 5.6 mM glucose, but we were unable to detect an increase in O-GlcNAcylation of PCNA after exposure to high glucose or glucosamine for 12 h (Fig. 4D) . Likewise, there were no changes in O-GlcNAcylated PCNA when cells were exposed to glucosamine for up to 48 h (data not shown). mTOR mediates proliferative response to high glucose and glucosamine. The mTOR is a serine (Ser)/threonine (Thr) kinase that plays a critical role in cellular nutrient sensing, energy balance, growth, proliferation, and survival. Rapamycin or its analogs (rapalogs) complex with FK506 binding protein-12 and subsequently act as a specific allosteric inhibitor of mTOR (1) . mTOR can exist in one of two complexes, mTORC1 and mTORC2; rapalog sensitivity appears to be limited to mTOR within mTORC1 (1) . As an approach to ascertain the role of mTOR in MC response to either high glucose (25 mM) or glucosamine (0.05 mM), we examined the proliferative response under either of these conditions, in the presence of rapamycin (25 nM). The latter concentration for rapamycin has been shown to inhibit mTORC1-dependent downstream effects without affecting mTORC2-dependent events (62, 63) . Our initial observation was that rapamycin inhibited both high glucose-and glucosamine-induced MC proliferation (Fig. 5A) . Furthermore, we observed that total Raptor, a component of mTORC1, was increased following 12 h of exposure to either high glucose or glucosamine (Fig. 5B) , but, by 24 h, there were no differences in total Raptor derived from cells cultured under the three conditions (Fig. 5C) . mTOR phosphorylation at serine residue 2448 correlates with mTOR activation in response to mitogenic stimuli (6) . As depicted in Fig. 5B , the levels of phospho-mTOR (Ser 2448 ) increased following 12 h of exposure to both high glucose and glucosamine (0.05 mM). However, after 24 -48 h of exposure to these external perturbations, phosphor-mTOR (Ser 2448 ) levels were indistinguishable from that seen with physiological glucose (Fig. 5C) ; there were no further changes following 48 h of exposure to high glucose or glucosamine (data not shown).
High glucosamine concentrations cause MC apoptosis. Apoptosis and proliferation are closely linked, for example, the anti-Thy1.1 model of glomerulonephritis is characterized by mesangiolysis, followed by MC proliferation and apoptosis (reviewed in Ref. 34) . Prolonged exposure (Ն48 h) to high concentrations of glucose and glucosamine are associated with apoptosis and changes in gene expression (20, 23, 57). Given the aforementioned reports and the current observation that prolonged exposure to elevated glucosamine (Ͼ200 M) led to attenuated MC proliferation, we sought to further characterize the relationship between enhanced hexosamine flux and apoptosis in MC. These series of experiments served to determine whether the effect(s) of high glucosamine concentrations (Ͼ0.02 mM) were quite distinct from those observed when cells were grown in media containing lower levels of glucosamine.
Apoptosis was assessed by DAPI nuclear staining, TUNEL, detection of a sub-G 0 MC population by flow cytometry, and Western blot analysis of caspase-3 activation. MC exposed to glucosamine (0.25-10 mM) for 48 h underwent apoptosis as assessed by DAPI and TUNEL staining (Fig. 6, A and B) ; similar observations were made for MC cultured in 25 mM glucose for 48 h (data not shown). Quantification of TUNELpositive MC (Fig. 6C) revealed that there was a significant increase in apoptosis in 25 mM glucose compared with 5.6 mM glucose (1.6 Ϯ 0.3 vs. 0.6 Ϯ 0.2%, P Ͻ 0.05). There was also an increase in TUNEL-positive MC exposed to glucosamine (3-4%; P Ͻ 0.05). In accord with this finding, flow cytometry analyses showed that a sub-G 0 population of MC was evident in 25 mM glucose and 0.25-10 mM glucosamine (at 48 h) compared with 5.6 mM glucose levels (Fig. 6, D-F) . Caspase-3 activation accompanies apoptosis following exposure to a variety of stimuli, and activation can be detected by Western blot analysis of caspase-3 degradation products (26, 54) . Therefore, we examined the effect glucosamine and high glucose on levels of caspase-3 and its degradation products. For these experiments, we chose a glucosamine concentration of 0.25 mM based on our prior observation (Fig. 6C ) that this concentration was sufficient to induce cell death. Accordingly, we observed that procaspase-3 and its degradation products both increased within 24 h (Fig. 7, A-C) and then returned to baseline levels by 48 h (data not shown).
GFAT is a determinant of MC apoptosis. We have previously observed that increased flux through the hexosamine pathway, induced by GFAT overexpression, mimics some adverse effects of high glucose despite physiological concentrations of extracellular glucose (20, 21) . To further relate the hexosamine pathway to apoptosis in MC, we studied the effect of GFAT overexpression. MCs were transfected with either one of the following: an empty vector, pCIS, or pCIS-GFAT in 5.6 mM glucose (20) . The percentage of TUNEL-positive cells was 3.6 Ϯ 0.3% in MC transfected with pCIS-GFAT compared with 1.2 Ϯ 0.3% in MC transfected with pCIS (P Ͻ 0.05) (Fig. 8A) . The glutamine analog azaserine inhibits GFAT under physiological glucose conditions (20) . In this regard, we observed that azaserine (10 M) attenuated apoptosis in cells transfected with pCIS-GFAT. In contrast, inhibition of GFAT by azaserine (Fig. 8B ) had no effect on apoptosis induced by 10 mM glucosamine.
Glucosamine influences protein levels of p53, Bax, Bcl-2, and p21 in MC. To further explore link(s) between flux through the hexosamine pathway and apoptosis in MC, we studied the effect of glucosamine (10 mM) on the expression of the proapoptotic proteins, p53 (27) , and Bax, and the anti-apoptotic protein, Bcl-2 (46), by Western blot analysis (Fig. 9) . MC exhibited a threefold increase in p53 levels 4 and 8 h after exposure to 10 mM glucosamine (P Ͻ 0.02; Fig. 9A ). Bax levels peaked after 12 h (Fig. 9B) , whereas Bcl-2 levels decreased in MC exposed to glucosamine, reaching a nadir at 12 h (Fig. 9C) .
The cell cycle regulatory protein p21 plays a key role in p53-mediated mitotic arrest and cell fate and also serves as a major anti-proliferative factor (8, 14, 16, 50 ). In addition, p21 http://ajpendo.physiology.org/ may also inhibit proliferation by avidly binding to PCNA (40) . Accordingly, we examined p21 levels in MC exposed to 10 mM glucosamine and found that there was a time-dependent decrease in p21 (Fig. 9D) .
DISCUSSION
Flux through the hexosamine pathway is an important biochemical determinant of injury-related gene expression in glomerular MCs (20, 24) , and the hexosamine pathway has also been implicated in the arrest of cell cycle progression in MC (37) . In addition, renal proximal tubular cells (47) , podocytes (61) , and MC (23) exhibit apoptosis after exposure to high glucose concentrations, and an increase in TUNEL-positive cells has been observed in experimental and clinical diabetic nephropathy (30, 64, 70) , although a link to flux through the hexosamine pathway has not been established. Accordingly, we studied the relationship between flux through the hexosamine pathway and MC proliferation and apoptosis.
Our initial observation was that, like high glucose, MC exposed to glucosamine (0.05 mM) underwent proliferation (Fig. 1) . More importantly, glucosamine-induced MC proliferation was time dependent and was significantly greater than that seen in physiological glucose but, over 96 h, was similar to that seen with MC grown in high glucose-containing medium (Fig. 1) . Previous observations have shown that exposure to high glucose causes MC proliferation (66), but a role for hexosamine flux in this process was not addressed. More recently, glutamine (a substrate for generation of glucosamine via the hexosamine pathway) has been observed to augment glucose-induced MC proliferation (25) . Interestingly, in that study, GFAT inhibition significantly reduced glutamine-induced proliferation (Fig. 3) , supporting a role for the hexosamine pathway in this process (25) .
In our current study, to ascertain the role of hexosamine flux in high glucose-and glucosamine induced-proliferation, we studied the effect of GFAT inhibition on proliferation. These studies revealed that DON significantly blunted glucose-induced proliferation without affecting glucosamine-induced proliferation (Fig.  3B) . On the other hand, inhibition of O-GlcNAcase by PUGNAC enhanced proliferation in cells cultured in physiological glucose (Fig. 3B) . These observations support a direct link between hexosamine flux and proliferation. In concert with increased proliferation that was observed when MC were exposed to high glucose (25 mM) or glucosamine (0.05 mM), increased intracellular PCNA protein levels were also noted (Fig. 4) . Earlier studies have found that high glucose induces MC proliferation in concert with increases in PCNA (66) , in line with our observation for high glucose in the current series of experiments. On the other hand, in other studies, glucosamine (2 mM) was found to have no effect on PCNA levels in MCs (57), and glucosamine (2-5 mM) induced cell cycle arrests in these glomerular cells (37, 57) . Thus, our observation of MC proliferation at lower levels of glucosamine (0.05 mM) suggests a dual role for glucosamine on cell fate and is similar to observations made for high glucose.
The ability of glucose and glucosamine to increase hexosamine pathway metabolites has not been studied extensively. However, a detailed study by Marshall et al. (36) reported that the effects of these two nutrients are essentially congruent with respect to increasing intracellular UDP-GlcNAc only when either is present alone. Even under physiological glucose conditions, the effect of glucosamine is delayed because glucose has a higher affinity for the GLUT1 transporter and is believed to competitively attenuate glucosamine transport. An earlier study (49) suggested that uptake of glucose and glucosamine likely occurred via the same (glucose) transporter. Although both compounds had comparable maximum velocity, the Michaelis constant for glucose was 10-fold lower than that for glucosamine. This suggests that transport may be a limiting factor in downstream effects of glucosamine and, indeed, may contribute to a lag in the downstream effects of glucosamine (when compared with those of glucose). The delayed effect of glucosamine compared with glucose on PCNA, for example, is consistent with these earlier studies (36, 49) .
Given our observation that PCNA increased in MC exposed to both high glucose and glucosamine (0.05 mM) and the role of protein O-GlcNAcylation in cell behaviour (17) , we sought to determine whether PCNA was O-GlcNAcylated. Indeed, PCNA O-GlcNAcylation was observed at physiological glucose concentrations, but levels of O-GlcNAcylated PCNA were not affected over the time of study (Fig. 4) . Similarly, Fig. 8 . Glutamine:fructose-6-phosphate amidotransferase (GFAT) overexpression increases TUNEL-positive MC. A: MCs were transfected with pCIS (empty vector) or pCIS-GFAT and incubated for 18 h, and then the media were changed to DMEM-0.5% FBS with and without azaserine (10 mM) and cultured for an additional 24 h. Apoptosis was assessed by TUNEL staining. B: MCs were exposed to 10 mM glucosamine with and without azaserine (20 mM) for 24 h before performing TUNEL assay. Values are means Ϯ SD for 4 separate experiments. P Ͻ 0.05 vs. 5.6 mM glucose only or vs. 5.6 mM glucose with pCIS (*) and vs. pCIS-GFAT without azaserine (#). mTOR, a member of the phosphatidylinositol 3 family of kinases, is a Ser/Thr kinase that plays a critical role in cellular nutrient sensing, energy balance, growth, proliferation, and survival (1, 6) . mTOR can exist in a rapamycin-sensitive complex (mTORC1) whose other members include an adaptor protein, Raptor, and mLST8. A second, and distinct rapamycin-insensitive mTOR complex (mTORC2), has also been described (1, 7) . mTOR phosphorylation at serine residue 2448 appears to be necessary for execution of downstream effects like growth and proliferation (6, 51) . In this regard, we observed that, in MC exposed to either high glucose (25 mM) or glucosamine (0.05 mM), in addition to increases in total Raptor, there were increases in levels of phosphor-mTOR (Ser 2448 ). These observations (Fig.  5) suggest that activation of mTORC1 is associated with the proliferative response of MC following exposure to high glucose and glucosamine and are consistent with previous reports relating mTORC1 to proliferation (6, 51) . Interestingly, in experimental diabetes, mTOR inhibition may slow the progression of diabetic kidney disease (32, 67).
The second major observation arising out of the current series of experiments was that exposure of MC to higher levels of glucosamine (Ͼ0.2 mM) for Ͼ48 h blunted proliferation (Fig. 1) . Utilizing TUNEL assay and flow cytometry, we observed this attenuation of growth was accompanied by increased apoptosis (Fig. 6 ). In addition, there were increases in caspase-3 and caspase-3 degradation products (Fig. 7) . These observations are consistent with previous studies that link high glucose and glucosamine, as well as caspase-3 activation, with MC death (23, 54, 57) . The mechanism(s) responsible for the switch from prosurvival to prodeath signaling pathways are not entirely clear. Recent studies support the hypothesis that OGT and O-GlcNAcase modulate phosphorylation of key kinases and phosphatases that mediate cell cycle progression (59) . In this regard, OGT overexpression limits cell cycle progression by decreasing cellular levels p21 and cyclin D and E. This effect may account, at least in part, for the decrease in cell proliferation that we observed with higher concentrations of glucosamine. O-GlcNacase overexpression has the opposite effect and enhances cell cycle progression (60) . These changes are time dependent. With regard to cell survival, higher glucosamine concentrations and increased cellular O-GlcNAc reduce cellular ATP (19, 36) ; this change may in turn impact cell function and viability. Alternatively, increased flux through the hexosamine pathway has been reported to affect mitochondrial function (19) .
Subsequently, we sought to determine whether GFAT expression would mimic the effect of high doses of glucosamine on MC apoptosis. Indeed, overexpression of GFAT, the ratelimiting enzyme for flux through the hexosamine pathway, caused MC apoptosis that was attenuated by inhibition of GFAT enzymatic activity with azaserine (Fig. 8) . These obser- vations further implicate GFAT activity and flux through the hexosamine pathway as important mediators of this response. Apoptosis within tissues is a patchy process (42, 64) . In normal glomeruli and tubuli, the percentage of apoptotic cells has been found to be very low (Ͻ0.5%) and increased to three-to fourfold in persons with diabetic kidney disease (42, 64) . In accord with these reports, we observed that only about 1% of MCs were TUNEL positive in 5.6 mM glucose. Thus, the low percentage of MC apoptosis noted in our study is consistent with these recent reports (42, 64) .
Finally, we sought to determine whether glucosamine-induced MC apoptosis was associated with changes in proteins related to apoptosis and survival. The tumor suppressor protein p53 is a transcription factor that regulates the expression levels of many genes that modulate cellular response to external perturbations, including proapoptotic and prosurvival genes (55, 71) . The primary outcome of p53 action is growth arrest and apoptosis, depending on the nature of the stimuli and the cell type (27, 55, 71) . Accordingly, we examined the effect of glucosamine (10 mM) on p53 protein levels. In this regard, the results revealed that glucosamine caused a three-to fourfold increase in MC p53 levels that peaked at 4 h and was sustained for up to 8 h (Fig. 9A ). This observation is in line with other studies that link the hexosamine pathway to p53-dependent apoptosis (13) .
Apoptosis is associated with an increase in levels of proapoptotic proteins such as Bax and decrease in the levels of prosurvival proteins like Bcl-2 (23, 52, 68) . In line with these observations, we observed that glucosamine (10 mM) produced a significant increase in Bax levels that was accompanied by a concomitant decrease in Bcl-2 protein levels and occurred after the increase in p53 levels (Fig. 9 , B and C).
p21 plays a crucial key role in p53-mediated mitotic arrest and cell fate and also serves as a major anti-proliferative factor (8, 14, 16, 50 ). In the current study, p21 levels were significantly depressed following 16 h of exposure to glucosamine (10 mM), with recovery ensuing subsequently (Fig. 9D) . In vascular smooth muscle cells, p21 is permissive for proliferation at low levels of this protein and inhibitory at higher concentrations (2) . In addition, p21 inhibition may lead to apoptosis (12) . Thus the initial reduction in p21 levels in the current study likely relates to the early proliferation seen with glucosamine. With protracted exposure, p21 levels rise in concert with reduction in proliferation.
The current series of observations suggest that glucosamineinduced proliferation occurs at low concentrations of this metabolite, whereas protracted exposure to higher concentrations leads to apoptosis in a manner that is similar to that observed with high glucose. These observations may explain the conflicting data that has been observed with respect to the effect of glucosamine on various cell types. In the context of chronic kidney disease, given that MC depletion is a prominent feature of diabetic glomerulosclerosis, these findings may have important long-term implications for glomerular cells in the diabetic kidney. Future studies will be necessary to further define the various signaling pathways that may participate in hexosamine-mediated MC proliferation and apoptosis, and to determine how these signals are modulated.
